Three-Fraction Intra-Cavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen
We report outcomes of a prospective trial evaluating adjuvant 3-fraction intra-cavitary accelerated partial breast brachytherapy for women with early stage breast cancer. With early follow-up, we have identified low rates of adverse events, favorable patient-reported quality of life, and a high rate of excellent or good breast cosmesis. These data are promising and warrant further study.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Krishan R. Jethwa, Sean S. Park, Karthik Gonuguntla, Stephanie M. Wick, Laura A. Vallow, Christopher L. Deufel, Thomas J. Whitaker, Keith M. Furutani, Kathryn J. Ruddy, Kimberly S. Corbin, Tina J. Hieken, Robert W. Mutter Source Type: research
More News: Biology | Brachytherapy | Breast Cancer | Cancer | Cancer & Oncology | Physics | Radiology | Study | Women